Helios Flexi Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Helios Flexi Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Helios Flexi Cap Fund - Direct (G)

7.29%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

-

-

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

7577.33

-

15.82

October 23, 2023

-

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

-

-

7.29 %

14.01 %

19.35 %

7.4 %

Alok Bahi

Undergraduate degree in Commerce from Punjab University, Chandigarh, Post Graduate Diploma in Financial Management from K.C. College of Management Post Graduate Certificate in Business Management from XLRI Jamshedpur.

Over 32 years of experience: Mr. Alok has been associated with Helios Group since 2005. Prior to joining Helios Capital Asset Management (India) Private Limited in April 2023 as CIO, he was a senior member of the investments team at Helios Capital Management Pte. Ltd., Sin-gapore for 18 years. Prior to joining Helios Group, Alok worked in India with various sell side firms in sales for over 14 years.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right